Lonza Sees Maturing Projects Driving Profitability Higher Over Medium Term
By Adria Calatayud
Lonza Group said it expects maturing growth projects and cost discipline to boost profitability over the medium term, as the group reiterated its full-year outlook.
The Swiss company on Wednesday laid out its midterm growth targets that reflect its transformation into a group purely focused on the contract drug-manufacturing business following the planned sale of its capsules-and-health-ingredients unit to Lone Star Funds.
Lonza said it aims to accelerate the expansion of its core margin for earnings before interest, taxes, depreciation and amortization to reach a figure in the high thirties percentage range in the medium term, while targeting organic sales growth excluding currency movements in the low-teens range--between 10% and 13%--on average over time.
The company said this marked an upgrade to its midterm ambitions, which previously included organic sales growth at constant currency in the low-teens range on average and profitability expanding faster than sales.
For 2026, Lonza reiterated its outlook of sales growth of between 11% and 12% at constant currency, and a core Ebitda margin of between 33% and 34%.
The group's third-quarter performance was in line with its expectations across all business platforms, it said.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
October 14, 2026 01:28 ET (05:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
United States